Integrated Technology Resource for Polymeric Biomaterials

高分子生物材料综合技术资源

• 批准号: 7198148
• 负责人: Joachim B. Kohn
• 金额: $ 94.01万
• 依托单位: RUTGERS, THE STATE UNIV OF N.J.
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-04-01 至 2008-04-06
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7198148
• 关键词: Address; Area; Biochemical; Biocompatible Materials; Biological; Biomaterials Research; Biomedical Engineering; Biomedical Research; Cells; Cellular biology; Ceramics; Chemicals; Clinical; Collaborations; Communities; Compatible; Complement; Complex; Condition; Confocal Microscopy; Dentistry; Depth; Development; Devices; Drug Delivery Systems; Education; Educational workshop; Electron energy loss spectroscopy; Engineering; Ensure; Faculty; Funding; Gene Delivery; Generations; Goals; Imaging technology; In Situ; Institutes; Institution; Kilogram; Knowledge; Laboratories; Ligaments; Medical; Medical Device; Medicine; Metals; Methods; Modality; Molecular; Molecular Biology; Nanostructures; National Center for Research Resources; New Jersey; Oils; Pharmaceutical Preparations; Plastics; Polymers; Process; Production; Property; Publications; Range; Research; Research Infrastructure; Research Personnel; Research Project Grants; Residencies; Resources; Science; Services; Standards of Weights and Measures; Structure; Surface; Technical Expertise; Techniques; Technology; Testing; Tissue Engineering; Tissues; Today; Training; Training Programs; United States National Institutes of Health; Universities; Vascular Graft; Washington; Wound Healing; analytical tool; base; biocompatible polymer; biological research; clinical application; combinatorial; copolymer; design; implant material; medical implant; medical implant science; monomer; nanoscale; novel therapeutics; posters; programs; research and development; response; scale up; symposium

DESCRIPTION (provided by applicant): Ongoing advances in understanding cell biology, wound healing and targeted drug effects are creating opportunities for the use of degradable, biocompatible polymers in unprecedented ways. The Resource for Polymeric Biomaterials, RESBIO, will bring advanced materials science to the service of the biomedical community through integrated technologies for a) synthesis and processing, b) micro- and nanoscale structure determination, and 3) characterization of both materials and their interactions with cells. Taking advantage of the relationships among these technologies for the ultimate control of cellular responses is a powerful approach to advancing clinical applications of biomaterials; this is the central strategy of RESBIO. A distinctive resource cluster will be created and hosted by the New Jersey Center for Biomaterials, a thriving academic consortium of New Jersey's premier institutions of higher education. This resource will focus on the synthesis of polymer biomaterials, scale-up of production to kilogram levels, processing, and characterization of bulk material properties using the techniques of materials science, engineering, and molecular biology. RESBIO will interact closely with and complement the NCRR-funded National ESCA and Surface Analysis Center for Biomedical Problems (NESAC/BIO). Core technological R&D projects will focus on combinatorial and computational approaches to polymer design, high-throughput and biorelevant characterization, profiling bulk biomaterial micro- and nanostructure, and in situ cell profiling. Collaborations will involve both basic biochemical/biomaterials research and the development of medical devices such as ligament replacements and vascular grafts. RESBIO laboratories will provide integrated services spanning parallel polymer synthesis, polymer processing, electron energy loss spectroscopy, and multiphoton confocal microscopy. Dissemination activities will feature scholarly publications, professional development short courses and workshops, conference and poster presentations, and a comprehensive website. A broad training program will include postdoctoral residencies in an NIH-funded training program and graduate courses.

描述（由申请人提供）：在理解细胞生物学、伤口愈合和靶向药物作用方面的持续进展为以前所未有的方式使用可降解、生物相容性聚合物创造了机会。聚合物生物材料资源，RESBIO，将带来先进的材料科学服务的生物医学界通过综合技术a）合成和加工，B）微米和纳米结构的测定，和3）表征两种材料及其与细胞的相互作用。利用这些技术之间的关系来最终控制细胞反应是推进生物材料临床应用的有力方法;这是RESBIO的核心战略。一个独特的资源集群将创建和主办的新泽西中心生物材料，一个蓬勃发展的学术财团的新泽西的首要高等教育机构。该资源将侧重于聚合物生物材料的合成，生产规模扩大到公斤级，加工和使用材料科学，工程和分子生物学技术表征散装材料的特性。RESBIO将与NCRR资助的国家ESCA和生物医学问题表面分析中心（NESAC/BIO）密切互动并相互补充。核心技术研发项目将侧重于聚合物设计的组合和计算方法，高通量和生物相关表征，分析散装生物材料的微观和纳米结构，以及原位细胞分析。合作将涉及基础生物化学/生物材料研究以及韧带置换和血管移植等医疗器械的开发。RESBIO实验室将提供综合服务，涵盖并行聚合物合成，聚合物加工，电子能量损失光谱和多光子共聚焦显微镜。传播活动将包括学术出版物、专业发展短期课程和讲习班、会议和海报展示以及一个综合网站。一个广泛的培训计划将包括在NIH资助的培训计划和研究生课程博士后住院。